Science evolves as both controlled clinical research and real-world evidence show us how to use health care technologies to ...

Ultromics announced that it raised $55 million in a Series C financing to support its AI-powered heart failure diagnostic ...

Biotech leaders talked about artificial intelligence and the state's life sciences lead at the Business Journal's summer ...

Carlsmed (Nasdaq:CARL) today announced new technology add-on payment (NTAP) reimbursement for its spine implant technology.

Erasca Inc. (NASDAQ:ERAS) is one of the stocks under $10 to buy now. Earlier on June 2, Erasca announced that the US FDA had cleared its Investigational New Drug/IND application for ERAS-4001.

ImmunityBio, Inc. (NASDAQ: IBRX) is one of the penny stocks that will skyrocket. On July 25, the company confirmed it is ...

Maybe someone you know had an extra refill, or they had leftovers after recovering from surgery. But is it legal?

The venture capital arms of Pittsburgh-based UPMC and UChicago Medicine have invested in a healthcare AI startup as part of a $55 million series C funding round. UPMC Enterprises and UCM Ventures ...

From new payload linkers to artificial intelligence partnerships, advances in ADC pipelines push forward selective cancer therapies that minimize side effects.

Carlsmed, Inc. ('Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Hospital Inpatient Prospective Payment Systems Final ...

The breakome is a new layer in the multiomics landscape—alongside the genome, transcriptome, proteome, and interactome. While it hasn’t traditionally been included among these other omics, we consider ...

In line with President Donald Trump's “most favored nation” model, letters were sent Thursday to 17 of the world's biggest drug companies demanding price cuts for Americans and direct-to-consumer ...